A detailed history of Td Asset Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Td Asset Management Inc holds 44,994 shares of RPRX stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,994
Previous 44,172 1.86%
Holding current value
$1.09 Million
Previous $1.16 Million 9.28%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$25.63 - $29.27 $21,067 - $24,059
822 Added 1.86%
44,994 $1.27 Million
Q2 2024

Aug 02, 2024

SELL
$26.26 - $29.9 $653,348 - $743,912
-24,880 Reduced 36.03%
44,172 $1.16 Million
Q1 2024

May 08, 2024

SELL
$27.46 - $31.33 $4.15 Million - $4.73 Million
-151,131 Reduced 68.64%
69,052 $2.1 Million
Q4 2023

Feb 12, 2024

SELL
$26.21 - $29.22 $1.84 Million - $2.05 Million
-70,300 Reduced 24.2%
220,183 $6.18 Million
Q3 2023

Oct 27, 2023

BUY
$26.26 - $31.38 $2.52 Million - $3.01 Million
96,026 Added 49.38%
290,483 $7.88 Million
Q2 2023

Aug 09, 2023

SELL
$29.6 - $36.56 $232,537 - $287,215
-7,856 Reduced 3.88%
194,457 $5.98 Million
Q1 2023

May 10, 2023

BUY
$32.77 - $39.4 $32,638 - $39,242
996 Added 0.49%
202,313 $7.29 Million
Q4 2022

Feb 06, 2023

BUY
$39.17 - $44.04 $387,312 - $435,467
9,888 Added 5.17%
201,317 $7.96 Million
Q3 2022

Nov 07, 2022

SELL
$39.88 - $44.65 $572,198 - $640,638
-14,348 Reduced 6.97%
191,429 $7.72 Million
Q2 2022

Aug 04, 2022

BUY
$37.53 - $44.22 $1.42 Million - $1.67 Million
37,742 Added 22.46%
205,777 $8.65 Million
Q1 2022

May 10, 2022

BUY
$37.46 - $42.44 $23,524 - $26,652
628 Added 0.38%
168,035 $6.55 Million
Q4 2021

Feb 10, 2022

BUY
$35.17 - $42.48 $454,220 - $548,629
12,915 Added 8.36%
167,407 $6.67 Million
Q3 2021

Nov 09, 2021

SELL
$36.14 - $42.24 $36,140 - $42,240
-1,000 Reduced 0.64%
154,492 $5.58 Million
Q2 2021

Aug 11, 2021

BUY
$39.85 - $46.63 $99,625 - $116,575
2,500 Added 1.63%
155,492 $5.94 Million
Q1 2021

May 14, 2021

BUY
$42.34 - $52.82 $245,572 - $306,356
5,800 Added 3.94%
152,992 $6.67 Million
Q4 2020

Feb 16, 2021

SELL
$36.12 - $50.05 $4.03 Million - $5.59 Million
-111,699 Reduced 43.15%
147,192 $7.37 Million
Q3 2020

Nov 10, 2020

BUY
$38.56 - $48.36 $2.7 Million - $3.39 Million
70,000 Added 37.06%
258,891 $10.9 Million
Q2 2020

Aug 13, 2020

BUY
$44.5 - $52.11 $8.41 Million - $9.84 Million
188,891 New
188,891 $9.17 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.